A ngiotensin II (Ang II) contributes to vascular disease with multiple risk factors. [1] [2] [3] This member of the reninangiotensin system exerts pleiotropic effects, increasing vascular tone while activating pro-oxidant and proinflammatory signaling that affects endothelial function and other aspects of vascular biology. Although many effects of Ang II are mediated by the angiotensin II receptor type 1 (AT1) receptor, 3 mechanisms that control this signaling at the cellspecific level in intact vessels are still not well defined. Although the net effect of Ang II reflects integrated mechanisms, the relative importance of mechanisms that protect against vascular effects of Ang II is unclear.
In contrast to Ang II, pharmacological activation of PPAR-γ (peroxisome proliferator-activated receptor-γ) with high affinity ligands (eg, thiazolidinediones) promotes vasodilation along with anti-oxidant and anti-inflammatory effects. 4 Although such effects are well described, much less is known on the impact and targets of PPAR-γ at the cell-specific level (in the absence of pharmacological activation). In vascular muscle, PPAR-γ influences function through mechanisms that include interactions with cullin-3 and RhoA with no apparent role for oxidative stress. [5] [6] [7] Although transcription factors often exert cell-specific effects, much less is known on the extent and mechanisms by which PPAR-γ affects endothelium. Thus, it is difficult to predict whether the mechanisms and targets of PPAR-γ in endothelium are similar to those in other cell types.
We found recently that after genetic interference with endothelial PPAR-γ, a nonpressor dose of Ang II produces superoxide-mediated endothelial dysfunction in male mice. Abstract-Pharmacological activation of PPAR-γ (peroxisome proliferator-activated receptor-γ) protects the vasculature.
Much less is known on the cell-specific impact of PPAR-γ when driven by endogenous ligands. Recently, we found that endothelial PPAR-γ protects against angiotensin II-induced endothelial dysfunction. Here, we explored that concept further examining whether effects were sex dependent along with underlying mechanisms. We studied mice expressing a human dominant-negative mutation in PPAR-γ driven by the endothelial-specific vascular cadherin promoter (E-V290M), using nontransgenic littermates as controls. Acetylcholine (an endothelium-dependent agonist) produced similar relaxation of carotid arteries from nontransgenic and E-V290M mice. Incubation of isolated arteries with angiotensin II (1 nmol/L) overnight had no effect in nontransgenic, but reduced responses to acetylcholine by about 50% in male and female E-V290M mice (P<0.05). Endothelial function in E-V290M mice was restored to normal by inhibitors of superoxide (tempol), NADPH oxidase (VAS-2870), Rho kinase (Y-27632), ROCK2 (SLX-2119), NF-κB (nuclear factor-kappa B essential modulator-binding domain peptide), or interleukin-6 (neutralizing antibody). In addition, we hypothesized that PPAR-γ may influence the angiotensin 1-7 arm of the renin-angiotensin system. In the basilar artery, dilation to angiotensin 1-7 was selectively reduced in E-V290M mice by >50% (P<0.05), an effect reversed by Y-27632. Thus, effects of angiotensin II are augmented by interference with endothelial PPAR-γ through sex-independent mechanisms, involving oxidant-inflammatory signaling and ROCK2 (Rho kinase). The study also provides the first evidence that endothelial PPAR-γ interacts with angiotensin 1-7 responses. These critical roles for endothelial PPAR-γ have implications for pathophysiology and therapeutic approaches for vascular disease. (Hypertension. 2017;70:559-
The goal of this study was to pursue those findings, examining mechanisms in greater detail while determining whether effects of endothelial PPAR-γ were sex dependent. Because the renin-angiotensin system functions at both the local and systemic level, 3 we used a model that examines direct effects of Ang II on the vessel wall. This approach has been used to study effects of Ang II and other mediators of disease. [9] [10] [11] [12] [13] [14] In relation to end-organ damage, we studied carotid arteries because the clinical impact of vascular disease is often seen in that vessel. 15, 16 In addition to activating AT1 receptor, Ang II can be converted to angiotensin 1-7 (Ang 1-7), a peptide that provides a mechanistic balance by countering effects of Ang II. 17 Very little is known on potential interactions between PPAR-γ and Ang 1-7. We hypothesized that in addition to affecting Ang II-mediated effects, PPAR-γ may influence responses to Ang 1-7. Thus, we tested the hypothesis that vascular responses to Ang 1-7 are impaired after interference with endothelial PPAR-γ. Our key findings were that genetic interference with PPAR-γ in endothelium augments effects of Ang II while suppressing effects of Ang 1-7. Oxidative stress, local inflammation, and activation of ROCK (Rho kinase) were identified as contributing factors to these effects.
Materials and Methods

Experimental Animals
Protocols were approved by the University of Iowa Animal Care and Use Committee. Care of mice met the standards set forth by the National Institute of Health for the use of experimental animals. We studied mice expressing a dominant-negative mutation in human PPAR-γ under control of the endothelial-specific vascular cadherin promoter (designated E-V290M, n=57) 18 and nontransgenic (nonTg) littermates (n=55). The use of littermates provides the best control in relation to genetics and environment (intrauterine and postbirth environment) along with diet, age, and so forth. Mice were fed standard chow and water ad libitum. Details on the experimental procedures and the rationale for the concentration of Ang II used are presented in the Materials and Methods in the online-only Data Supplement.
Statistical Analysis
All data are expressed as mean±SE. Data were evaluated using an unpaired t test or 2-way ANOVA followed by Bonferroni post hoc test as appropriate. Statistical significance was accepted at P <0.05.
Results
Ang II Impairs Endothelial Function in E-V290M Mice in a Sex-Independent Manner
Responses of carotid arteries to acetylcholine were not different in male and female mice after vehicle treatment (P>0.05; Figure 1 ). Endothelial-specific interference with PPAR-γ in the absence of any other treatment did not affect this response in female or male mice ( Figure 1 ). With 1 exception at a single submaximal concentration of acetylcholine in male mice, the relatively low concentration of Ang II (1 nmol/L) had no significant effect on vasorelaxation in female or male non-Tg mice ( Figure 1 ). In contrast, this same concentration of Ang II greatly impaired responses to acetylcholine in E-V290M mice, with similar effects in females and males ( Figure 1 ). Endothelium-independent relaxation to nitroprusside was not significantly affected by Ang II, PPAR-γ genotype, or sex of the mice (Figure 1 ). For ease of comparison, maximum effects of acetylcholine and nitroprusside are presented in Figure 2 . Because there were no sex-dependent differences, data obtained from males and females were combined in subsequent groups. Contraction of arteries to U46619 was also not affected by genotype or Ang II ( Figure S1 in the online-only Data Supplement).
Role of Oxidative Stress and NADPH Oxidase in E-V290M Mice
We found recently that interference with PPAR-γ in endothelial cells enhanced Ang II-induced increases in superoxide and endothelial dysfunction. 8 Consistent with that observation, Ang II impaired relaxation of carotid arteries to acetylcholine through a tempol-sensitive mechanism in E-V290M mice ( Figure 3A ). Because the underlying mechanism was unknown, 8 we tested effects of an inhibitor of NADPH oxidase (VAS-2870).
19 VAS-2870 had no effect on responses in non-Tg mice but restored endothelial function in arteries from E-V290M mice after Ang II ( Figure 3B ). Relaxation of arteries to nitroprusside was not affected by Ang II or tempol or VAS-2870 ( Figures S2 and S3 ).
Endothelial Dysfunction in E-V290M Mice: Impact of NF-κB and Interleukin-6
PPAR-γ interacts with NF-κB (nuclear factor-kappa B), inhibiting its activation. 4 NADPH oxidase is also a target Figure 1 . Responses of carotid arteries to acetylcholine and nitroprusside in female (A; n=21) and male (B; n=21) nontransgenic (non-Tg) and female (n=21) and male (n=23) endothelial-specific vascular cadherin promoter (E-V290M) mice after incubation with angiotensin II (Ang II). All data are mean±SE. Statistical differences were based on 2-way ANOVA followed by Bonferroni post hoc test. *<0.05 vs vehicle within the same genotype.
of NF-κB. 20 We found previously that Ang II alters vascular expression of NF-κB components (eg, increased p65 protein) in E-V290M mice, 8 but the functional impact of NF-κB or downstream targets was not tested. Human fibroblasts from individuals carrying dominant-negative mutations in PPAR-γ produce increased levels of interleukin-6 (IL-6), a target of NF-κB. 21 With this background, we treated arteries with a cell-penetrating NF-κB essential modulator-binding domain peptide 12 (an inhibitor of NF-κB activation) or an IL-6 neutralizing antibody 12 (during the incubation protocol). These treatments did not affect vascular responses under control conditions, but prevented Ang II-induced endothelial dysfunction in E-V290M mice ( Figure 4A and 4B). Relaxation of arteries to nitroprusside was not affected by either inhibitor (Figures S4 and S5) . Treatment with the control peptide had no significant effect on relaxation to acetylcholine or nitroprusside ( Figure 4A ; Figure S4 ).
Role of Rho Kinase in E-V290M Mice
ROCK (Rho kinase) has been linked to oxidative stress, inflammation, and endothelial dysfunction. 22, 23 Interactions between PPAR-γ, RhoA (an activator of ROCK), and ROCK have been observed in vascular muscle. 5, 6, 24 Whether similar interactions occur between PPAR-γ and ROCK in endothelial cells is less clear. Thus, we examined effects of Y-27632, which inhibits both ROCK1 and ROCK2 isoforms equally effectively. 22 Y-27632 did not affect vascular responses in non-Tg mice, but restored endothelial function in arteries from E-V290M mice treated with Ang II ( Figure 5A ).
Although both isoforms of ROCK are expressed in vascular cells, 5, 23, 24 the importance of each is poorly understood. Thus, we tested effects of a selective ROCK2 inhibitor (SLX-2119) in this study. SLX-2119 did not affect responses in controls, but restored endothelial function in E-V290M mice treated with Ang II (Figure 5B ). Relaxation to nitroprusside was not affected by Y-27632 or SLX-2119 ( Figures S6 and S7) .
Impact of PPAR-γ Interference on Vascular Effects of Ang 1-7
Next, we examined potential interactions between PPAR-γ and Ang 1-7, first testing effects of Ang 1-7 on vascular tone. Similar to effects seen in aorta, 25 Ang 1-7 produced modest relaxation in carotid arteries from C57BL/6 mice ( Figure S8 ). This modest effect was somewhat surprising because Ang 1-7 produces substantial vasodilation in cerebral arteries, 6 ,26 but may reflect heterogeneity in the distribution of mas receptors. Thus, we shifted attention to basilar arteries for the remainder of the study. Baseline diameter and constriction of the basilar artery to KCl were similar in non-Tg and E-V290M mice ( Figure 6A and 6B) . Both acetylcholine and Ang 1-7 dilated the basilar artery in non-Tg mice ( Figure 6C and 6D). Interestingly, vasodilation to Ang 1-7 was substantially reduced in E-V290M mice, whereas responses to acetylcholine were not significantly affected ( Figure 6C and 6D) . This effect was similar in male and female mice ( Figure S9 ) and was reversed by Y-27632 ( Figure 6D ).
Discussion
There are several new findings in this study. First, genetic interference with PPAR-γ in endothelial cells did not affect carotid arteries under baseline conditions but augmented direct effects of Ang II on endothelial function. Second, effects of the mutation in PPAR-γ and Ang II were sex independent. Third, Ang II-induced endothelial dysfunction in E-V290M mice was prevented by a scavenger of superoxide or inhibitors of NADPH oxidase, NF-κB, or IL-6. Fourth, Ang II-induced endothelial dysfunction was dependent on ROCK, Responses of carotid arteries to acetylcholine in nontransgenic (nonTg) and endothelial-specific vascular cadherin promoter (E-V290M) mice after incubation with angiotensin II (Ang II) or vehicle in the absence or presence of tempol (A; n=7 non-Tg and n=8 E-V290M) or VAS-2870 (B; n=6 non-Tg and E-V290M). Statistical differences were based on 2-way ANOVA followed by Bonferroni post hoc test. *P<0.05 vs vehicle.
with a major contribution by ROCK2. Fifth, in the absence of Ang II, interference with endothelial PPAR-γ reduced effects of Ang 1-7 in the basilar artery (a resistance vessel) via a ROCK-dependent mechanism. Overall, these studies provide new insight into mechanisms by which endothelial PPAR-γ protects the vasculature, including specific targets. In addition to its influence on Ang II-mediated effects, endothelial PPAR-γ interacts with Ang 1-7 responses.
Sex-Dependent Effects of Ang II and PPAR-γ Interference?
Ang II plays a key role in diverse preclinical models and is a major therapeutic target in humans. [1] [2] [3] Because local sources of Ang II are well described, 3 we tested direct effects of Ang II on the vessel wall. In this model, Ang II produces concentration-dependent effects on endothelial function, mediated by the AT1 receptor. [10] [11] [12] Like any cell or organ culture experiment, the model has limitations. However, such approaches have been predictive of changes seen in vivo and gaining mechanistic insight. [8] [9] [10] [11] 13, 14, 27 We confirmed that a low concentration of Ang II does not alter endothelial function in control mice. [10] [11] [12] Interestingly, impairment of endothelial function in arteries from E-V290M mice treated with 1 nmol/L Ang II was similar in magnitude to that produced by a 10-fold higher concentration of Ang II in non-Tg mice. [10] [11] [12] Thus, interference with PPAR-γ in endothelial cells is sufficient to substantially increase vascular sensitivity to Ang II.
Some cardiovascular effects of Ang II are sex dependent. 28, 29 In contrast, we found that the direct effect of Ang II on endothelial function was not sex dependent in E-V290M mice. Although that finding is somewhat surprising, there are studies in humans and animal models where effects of Ang II were sex independent and also cases where Ang II caused greater vascular responses in women than in men. [30] [31] [32] Thus, when the broader literature is considered, the lack of sexdependent effects of Ang II in this study is perhaps less of a surprise.
In contrast to many previous studies, we did not use young mice, rather we studied mice well into mid-life (>1 year of age). Mid-life is when vascular disease and its clinical impact typically begin to emerge. We used older animals in an attempt to add relevance to the model in relation to vascular disease. Although we did not assess female mice in relation to the stage of their estrous cycle in this study, the mice were well into the age range where reductions or cessation of reproductive cyclicity occur. 33 We speculate that potential sexdependent and estrous cycle-dependent effects of Ang II on endothelial function may be present in younger mice but were lost by the age of study used here.
Patients with dominant-negative mutations in PPAR-γ (eg, V290M) exhibit early-onset hypertension. 34 Mice expressing these same mutations provide insight into cell-specific effects of PPAR-γ when driven by endogenous ligands. Although the use of mice expressing human gene mutations with known clinical impact can increase relevance in relation to human Responses of carotid arteries to acetylcholine in nontransgenic (nonTg) and endothelial-specific vascular cadherin promoter (E-V290M) mice after incubation with angiotensin II (Ang II) or vehicle in the absence or presence of the NF-κB (nuclear factor-kappa B) essential modulator-binding domain (NBD) peptide (A; n=5 non-Tg and E-V290M) or the interleukin-6 (IL-6) neutralizing antibody (B; n=6 non-Tg and E-V290M). Statistical differences were based on 2-way ANOVA followed by Bonferroni post hoc test. *P<0.05 vs vehicle. disease, 35 little is known on sex-dependent effects of PPAR-γ in the vasculature. In some studies, sex-dependent differences were not seen for vascular end points that included endothelial function. 6, 36 In contrast, sex-dependent differences for some vasoconstrictors were seen in a model expressing dominantnegative PPAR-γ in all cells.
37
Effects of Ang II Require Oxidant-and Inflammatory-Related Mechanisms
Independent of effects on arterial pressure, Ang II produces pro-oxidant and proinflammatory effects 2,3,27 that promote vascular disease and are propagated via intermediates that include reactive oxygen species and cytokines. 2, 3, 11, 27, 38 Ang II increases superoxide through several mechanisms, including activation of NADPH oxidase. 2, 3, 27, 39 The current finding that interference with endothelial PPAR-γ produced NADPH oxidasedependent endothelial dysfunction expands this concept and is consistent with previous findings of increased expression of NADPH oxidase components in E-V290M mice. 8, 18 Also consistent with such a mechanism, tempol restored acetylcholine-induced vasodilation in the current and a previous study. 8 Although our results support a role for NADPH oxidase, other sources of reactive oxygen species may be activated or interact with NADPH oxidase, including mitochondria. 2 An interesting concept that now arises relates to the cellspecific impact of PPAR-γ. Although it might be reasonable to predict that interference with PPAR-γ would produce oxidative stress in all cells within the vessel wall, interference in vascular muscle produces prominent phenotypes with no apparent role for oxidative stress. 6, 7 In contrast, the current and previous studies 8, 18 suggest that genetic interference with endothelial PPAR-γ predisposes to oxidative stress when combined with risk factors for disease. Despite these differences, ROCK plays a key role in both cell types.
Ang II activates NF-κB, a key integrator for expression of many inflammatory-related genes, including IL-6, a mediator of Ang II-induced vascular dysfunction and disease. 27, 38, 40 PPAR-γ regulates expression of target genes in part through interactions with NF-κB. 4 Supporting this concept, human fibroblasts from individuals carrying dominant-negative mutations in PPAR-γ produce increased levels of IL-6. 21 Few studies have examined the role of NF-κB in relation to endothelial function. For example, PPAR-γ protects against IL-1β-induced endothelial dysfunction, but the effect involves limiting oxidative stress, not activity of NF-κB. 14 In contrast, inhibiting activation of NF-κB or neutralizing IL-6 prevented endothelial dysfunction in vessels from E-V290M mice treated with Ang II. Both findings support the concept that effects of Ang II involve inflammatory-related signaling that is amplified after interference with endothelial PPAR-γ. Figure S10 presents a schematic diagram highlighting these mechanisms and potential interactions. We combined our cell-specific genetic approach with the use of several pharmacological inhibitors. None of the agents used altered endothelial function in arteries from non-Tg mice in the absence or presence of Ang II, which provides some evidence for selectively. With any pharmacological inhibitor, however, one can never be certain on a complete lack of off-target effects. We attempted to use best available agents (and combinations of drugs) when designing the study. NF-κB essential modulator-binding domain peptides, for example, are reportedly quite selective.
12
Endothelial PPAR-γ and Rho Kinase ROCK has emerged as a potentially important contributor to vascular disease. 22, 23 This concept is based in large part on studies using pharmacological inhibitors that reduce activity of both ROCK isoforms, and in some cases, other kinases as well. 22 Although Y-27632 and fasudil have similar inhibitory constants for both ROCK1 and ROCK2, 22 SLX-2119 is highly selective for ROCK2. 22 The findings in this study that both inhibitors had similar effects on endothelial function suggest that ROCK2 is the isoform primarily responsible for vascular dysfunction in E-V290M mice. Consistent with this study, we found that Ang II-induced endothelial dysfunction in control mice was prevented by inhibition of ROCK2.
22
Interactions Between PPAR-γ and Ang 1-7
In addition to the activation of AT1 receptor, Ang II can be converted to Ang 1-7. 17 Eliciting effects via the mas receptor, Ang 1-7 provides a mechanistic balance by countering effects of Ang II. 17 Little is known on mechanisms that regulate this protective portion of the renin-angiotensin system. We hypothesized that in addition to affecting Ang II and its downstream targets, 4 PPAR-γ may influence Ang 1-7-dependent responses but in an opposite manner.
In normal mice, Ang 1-7 produced relatively modest effects on tone in carotid arteries, but had substantial effects in cerebral arteries, consistent with previous work. 6, 26 Interestingly, vasodilation to Ang 1-7 was substantially reduced in basilar arteries from E-V290M mice, whereas responses to acetylcholine were not significantly affected. We speculate that receptor-specific differences in downstream signaling are responsible. Regardless, these findings provide the first evidence for interactions between endothelial PPAR-γ and Ang 1-7. These effects were also sex independent. Of note, the loss of Ang 1-7 effects after interference with PPAR-γ in endothelium was mediated by ROCK.
Perspectives
Hypertension continues to be a leading risk factor for vascular disease and stroke. Considering its fundamental role in vascular disease, we attempted to better define mechanisms that impact Ang II-mediated effects. Although pharmacological and genetic studies suggest that PPAR-γ plays a protective role in vascular disease, there are gaps in our understanding in relation to cell-specific effects and target molecules. The current studies support the concept that endothelial PPAR-γ plays an essential role in protecting the vessel wall while providing new insight into PPAR-γ targets and the functional importance of ROCK2.
Endothelial dysfunction and Ang II contribute importantly to the progression of atherosclerosis. Genetic studies in both humans and animals models support the concept that normal expression of PPAR-γ protects against atherosclerosis. 41, 42 Thus, the current finding of increased vascular sensitivity to Ang II after genetic interference with endothelial PPAR-γ has implications for progression of atherosclerosis. In addition, Ang II has been implicated in mechanisms that promote vascular disease in the face of other risk factors, including diabetes mellitus and aging. Further studies in this area may facilitate approaches that could be used to prevent, delay, and possibly reverse key elements of large and small vessel disease.
